Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Healthcare
TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
Advances TriSalus’ Platform Focused on Improving Outcomes for Patients with Liver and Pancreatic Cancer Expected to Advance Technology Development and...
Uniphar Group names Kay Bonavita, CCO, for Uniphar Logistics USA
RALEIGH, NC / ACCESSWIRE / August 10, 2023 / Uniphar Group names Kay Bonavita as Chief Commercial Officer for Uniphar...
Virginia’s Largest Ophthalmology, Optometry Clinic, and Storefront Transitions to eClinicalWorks Vision Solutions
50+ provider Virginia Eye Institute deploys eClinicalWorks EHR and healow patient engagement solutionsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,...
Altrua HealthShare Welcomes Jordan St. Cyr to Its Family as Both a Member and Ambassador for the Christian Health Share
AUSTIN, TX / ACCESSWIRE / August 10, 2023 / Altrua HealthShare has welcomed Juno Award-winning singer-songwriter Jordan St. Cyr to...
Lifeskills South Florida Opens New 34-Bed Fort Lauderdale Campus Providing Mental Health and Addiction Services
Responding to the growing need for detoxification services and acute mental health stabilization, Lifeskills added a campus in Ft. Lauderdale.BRENTWOOD,...
Imperative Care Unveils New Structure to Elevate Care for Patients with Vascular Diseases
A new business architecture connects the continuum of stroke and vascular care for patients from onset through post-acute careCAMPBELL, Calif.--(BUSINESS...
Biofrontera Inc. Announces Last Patient Enrolled in Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Basal Cell Carcinoma
Trial Results Expected in Mid-2024WOBURN, MA / ACCESSWIRE / August 10, 2023 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical...
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
Positive Duration of Remission Data Adds to Growing Body of Clinical Evidence Supporting APVO436 for the Treatment of AMLAPVO436 Poised...
Ainos Celebrates First Listing Anniversary on Nasdaq
Ainos reflects upon multiple business milestones following Nasdaq listing, as it diversifies its revenues and advances its product pipelineSAN DIEGO,...
Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
FORT LAUDERDALE, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”),...
Stereotaxis Reports 2023 Second Quarter Financial Results
ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
Inovalon Achieves NCQA HEDIS® Measure Certification for the 23rd Consecutive Year
Inovalon Converged Quality, Cloud Software Empowers More Than 80% of the Nation’s Clinical Outcomes Measurement AnalyticsBOWIE, Md., Aug. 10, 2023...
NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin
CARMEL, Ind., Aug. 10, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Indaptus Therapeutics Announces Opening of Next Cohort in Single Dose Ranging Study of Decoy20
Cohort 1 patients exhibited a significant immune response consistent with the mechanism of actionSafety Review Committee approved continuation to the...
GeneFab Launches to Offer Innovative Manufacturing and Synthetic Biology Design Services for a Broad Range of Genetic Medicines
– GeneFab’s cGMP facility in the San Francisco Bay Area has available capacity to support new customers with complex cell...
Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners
– Celadon Partners to acquire Senti’s manufacturing facility and CMC capabilities to establish GeneFab, an independent manufacturing business for cell...
Evoke Pharma Reports Second Quarter 2023 Financial Results
40% revenue growth compared to Q1 2023 34% increase in prescription fills compared to Q1 2023 Presented industry-leading real-world healthcare...
ABVC BioPharma Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
FREMONT, CA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical...
Vaxxinity Announces Publication of UB-311 Safety, Tolerability, Immunogenicity, and Clinical Efficacy Data from Phase 2a Trial in Alzheimer’s Disease
Phase 2a data published in The Lancet’s eBioMedicine supports further development of UB-311 The paper concludes that UB-311 is the...